Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Mary Ann Liebert, Inc., publishers, Publisher, 140 Huguenot Street, New Rochelle, NY.
Global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content to advance biotechnology, life sciences, specialized clinical medicine, and public health policy.
08/31/2025
🚨 Main Stage Spotlight: George Church, PhD
He’s helped shape the field of genomics. Now, George Church is taking the stage at State of Biotech 2025 for an unfiltered conversation about where science is headed next.
📍 “Church and State: A Conversation with George Church, PhD”
🕛 September 24 | 12:00–12:45 PM EDT
🎙️ Don’t miss this opportunity to hear from a true biotech pioneer.
NEW WEBINAR! Target, Track, Treat: Optimizing GI Cancer Management with Molecular Residual Disease Testing
Wednesday, September 10th, 2025
4:00 pm ET, 1:00 pm PT, 22:00 CET
In this panel, our industry experts will discuss the impactful role of circulating tumor DNA (ctDNA) testing for MRD assessment in GI cancer management. Key learnings for this webinar:
-The role of MRD testing in risk stratification, refining treatment pathways, and augmenting personalized oncology care
-Latest evidence supporting MRD as a predictive biomarker in GI malignancies, including its application in the neoadjuvant setting, adjuvant treatment decision-making, early relapse detection, ongoing surveillance, and informing metastatic directed therapy (MDT)
-How to integrate MRD testing into your practice to enable more precise, personalized, and timely treatment decisions
📢 The American Thyroid Association has released new management guidelines for adult patients with differentiated thyroid cancer, now available in Thyroid®.
These updated recommendations reflect significant progress in the understanding and treatment of papillary and follicular thyroid cancers, incorporating:
âś… More precise disease classification
âś… Risk-adapted treatment strategies
âś… Improved guidance for follow-up care
NEW WEBINAR! Practical Strategies to Enhance the Quality and Potency of mRNA Constructs
Monday, September 8th, 2025
8:00 am PT, 11:00 am ET, 17:00 CET
In this GEN Biotechnology webinar, Vicky Smith, PhD, an expert in RNA biology, will provide a practical blueprint for enhancing mRNA quality using proven manufacturing strategies from TriLink’s 25+ years of expertise. Register now to join us for this free webinar sponsored by TriLink BioTechnologies: https://hubs.li/Q03CRNJg0
08/14/2025
🧬 New research breakthrough in regenerative medicine
In a study led by Darryl D’Lima, MD, PhD, from the Shiley Center for Orthopaedic Research and Education at Scripps Clinic, researchers developed a scaffold-free method to produce cartilage using embryonic-derived mesenchymal stem cell (ES-MSC) spheroids.
The spheroids were cultured in chondrogenic medium and seeded into a customizable closed chamber system—where they fused into a single, functional tissue construct.
📢 The countdown to The State of Biotech 2025 begins!
On Wednesday, September 24 from 11:00 AM – 3:30 PM (EDT), The State of Biotech returns — hosted by Genetic Engineering & Biotechnology News — bringing together scientific leaders, business innovators, and policy experts to explore the breakthroughs and challenges shaping biotechnology today.
🎤 Keynotes from leaders advancing the frontiers of science
🧬 Panels on AI, CRISPR, and transformative therapeutics
đź’¬ Networking with thought leaders from across the life sciences
Reserve your spot now and be part of a global conversation on the future of healthcare.
đź”— https://hubs.li/Q03CbwfX0
07/29/2025
What does inclusive, patient-centered care for women really look like?
This article collection dives deep into women's health at the intersections of culture, trauma, equity, and innovation—exploring issues from diabetes in pregnancy to traditional practices and provider training.
🧠Curated from across Mary Ann Liebert, Inc. journals.
A new position statement from the UIAA Medical Commission dives into xenon inhalation as a method for rapid high-altitude adaptation—recently spotlighted by the New York Times after climbers used it to ascend Everest in just days.
🔍 New research spotlight: “Aligning AI with Human Values & Well-Being”
A multidisciplinary team writing in "Cyberpsychology, Behavior, and Social Networking" outlines a roadmap for humane-by-design AI—one that safeguards autonomy, equity, transparency, and long-term societal benefit.
Key takeaways:
• Six-pillar value-alignment framework (autonomy → sustainability)
• Case studies in healthcare & education
• Action steps for developers, policymakers, and end-users to keep people—not algorithms—at the center
Dive into "Tiny Traces, Big Impact: Revolutionizing Breast Cancer Management with MRD Testing"
⏰ Time: 1:00 pm PT | 4:00 pm ET | 10:00 CET
Join us, alongside Natera and Mary Ann Liebert, Inc., to discover how MRD testing is reshaping adjuvant therapy decisions. This is your chance to learn and engage with industry leaders!
🎉 Milestone unlocked: 50,000+ full-text downloads for AI in Precision Oncology!
This newly launched journal is already making an impact at the cutting edge of AI and individualized cancer care.
Led by Editor-in-Chief Douglas Flora, MD and Deputy Editor Nikhil Thaker, MD, the journal champions innovation, equity, and real-world application—with a powerhouse editorial board behind it. 💡🧬
Thank you to the contributors, readers, and editorial board members helping make this a vital space for collaboration and discovery.
More to come as we continue building a collaborative, real-world-impact forum for the future of AI in oncology.
DON'T MISS OUT!
Join us for "Tiny Traces, Big Impact: Revolutionizing Breast Cancer Management with MRD Testing"
🗓️ Mark Your Calendar: Tuesday, July 1st, 2025
⏰ Time: 1:00 pm PT | 4:00 pm ET | 10:00 CET
Proudly sponsored by Natera and hosted by Mary Ann Liebert, Inc., this webinar will explore how MRD testing is transforming adjuvant therapy decisions. Don't miss out on this opportunity to learn and engage!
Be the first to know and let us send you an email when Mary Ann Liebert, Inc., publishers posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Business
Send a message to Mary Ann Liebert, Inc., publishers:
Founded by Mary Ann Liebert in 1980, Mary Ann Liebert, Inc. is a leading independent publisher with a portfolio of over 90 peer-reviewed journals, leading trade magazines, and newsletters, in addition to society membership management and conferences.
Our publications focus on cutting-edge fields such as biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law, environmental research and policy, and other specialized disciplines.
We are, however, more than just a publisher. Mary Ann Liebert, Inc. collaborates effectively with corporations, educational institutions, nonprofit foundations, and is committed to meeting the needs of the members of academia, government, and industry around the world.
Browse our publications, explore the content of our established journals, and learn more about our extensive capabilities here: https://www.liebertpub.com/
